<?xml version="1.0" encoding="UTF-8"?>
<p>The search term “
 <italic>Holarrhena</italic>” was used to search PubMed while specifying article type “Clinical Trials”. Although no published papers with clinical studies were retrieved in this way, when we searched with the same term in Google scholar, more than a dozen publications were retrieved, most of them from India. The first clinical trial with alkaloids of 
 <italic>H. pubescens</italic> for the treatment of amoebic hepatitis was carried out by Chopra and De [
 <xref rid="B153-biomolecules-10-01341" ref-type="bibr">153</xref>]. However, they concluded that four doses of intramuscular injection of the total alkaloid mixture yields no improvement, while the patient complained of severe pain in the right hypochondriac region. Singh [
 <xref rid="B154-biomolecules-10-01341" ref-type="bibr">154</xref>] carried out a clinical study with 40 patients suffering from intestinal amoebiasis and/or giardiasis using 
 <italic>H. pubescens</italic>. In 70% of patients a response was observed in the 
 <italic>Entamoeba histolytica</italic> cysts, and the authors conclude that 
 <italic>H. pubescens</italic> (
 <italic>Kutaja</italic>) still remains a valuable remedy for amoebic infections.
</p>
